Definium Therapeutics Inc (DFTX)

Feb 05, 2026

Is Adsett’s Board Appointment And Breakthrough DT120 Status Altering The Investment Case For Definium Therapeutics (DFTX)? - simplywall.st

Feb 05, 2026

Feb 03, 2026

Pharma Co. Stole Secrets For LSD Medical Trials, Suit Says - Law360

Feb 03, 2026

Feb 03, 2026

Definium Therapeutics Announces New Employee Inducement GrantsFebruary 3, 2026 - BioSpace

Feb 03, 2026

Feb 02, 2026

Definium Therapeutics stock hits 52-week high at 18.19 USD By Investing.com - Investing.com Nigeria

Feb 02, 2026

Feb 02, 2026

LSD therapy biotech Definium sued for alleged trade secret theft | Business Information & News | FE - Westlaw Today

Feb 02, 2026

Feb 02, 2026

LSD therapy biotech Definium sued for alleged trade secret theft - Reuters

Feb 02, 2026

Feb 02, 2026

Company Researching LSD Applications Faces Trade Secrets Litigation in Delaware Federal Court - Law.com

Feb 02, 2026

Feb 02, 2026

Definium Therapeutics (NASDAQ:DFTX) Hits New 52-Week HighShould You Buy? - MarketBeat

Feb 02, 2026

Feb 02, 2026

Definium Therapeutics stock hits 52-week high at 18.19 USD - Investing.com

Feb 02, 2026

Feb 02, 2026

Cantor Fitzgerald reiterates Overweight rating on Definium stock By Investing.com - Investing.com UK

Feb 02, 2026

Feb 02, 2026

Cantor Fitzgerald reiterates Overweight rating on Definium stock - Investing.com

Feb 02, 2026

Feb 01, 2026

Definium Therapeutics (NASDAQ:DFTX) Research Coverage Started at Jefferies Financial Group - Defense World

Feb 01, 2026

Jan 31, 2026

Did Adding Biopharma Veteran Roger Adsett to the Board Just Shift Definium Therapeutics' (DFTX) Investment Narrative? - Yahoo Finance

Jan 31, 2026

Jan 31, 2026

Definium Therapeutics (NASDAQ:DFTX) Upgraded to Strong-Buy at Jefferies Financial Group - MarketBeat

Jan 31, 2026

Jan 30, 2026

Roger Adsett Joins Definium As Commercial Focus Meets Trial Milestones - Yahoo Finance

Jan 30, 2026

Jan 30, 2026

Definium Therapeutics Adds Commercial Leader As Phase 3 Milestones Approach - Sahm

Jan 30, 2026

Jan 30, 2026

Commit To Buy Definium Therapeutics At $10, Earn 21.9% Annualized Using Options - Nasdaq

Jan 30, 2026

Jan 30, 2026

Jefferies Initiates Coverage on Definium Therapeutics With Buy Rating, $30 Price Target - marketscreener.com

Jan 30, 2026

Jan 30, 2026

Jefferies initiates coverage on Definium Therapeutics stock with Buy rating - Investing.com India

Jan 30, 2026

Jan 30, 2026

Definium Therapeutics appoints Roger Adsett to board of directors By Investing.com - Investing.com Nigeria

Jan 30, 2026

Jan 30, 2026

Critical Contrast: Definium Therapeutics (NASDAQ:DFTX) vs. Tetra Bio-Pharma (OTCMKTS:TBPMF) - Defense World

Jan 30, 2026

Jan 30, 2026

Jefferies initiates coverage on Definium Therapeutics stock with Buy rating By Investing.com - Investing.com UK

Jan 30, 2026

Jan 29, 2026

Definium Therapeutics (DFTX) Expands Board with New Appointment - GuruFocus

Jan 29, 2026

Jan 29, 2026

Definium Therapeutics Appoints Roger Adsett To Board - citybiz

Jan 29, 2026

Jan 29, 2026

Definium Therapeutics Appoints Roger Adsett to Board of Directors, Effective from January 29, 2025 - marketscreener.com

Jan 29, 2026

Jan 29, 2026

Definium Therapeutics Expands Board, Appoints New Director - TipRanks

Jan 29, 2026

Jan 29, 2026

Definium Therapeutics appoints Roger Adsett to board of directors - Investing.com

Jan 29, 2026

Jan 29, 2026

Definium Therapeutics Appoints Roger Adsett to Board of Directors - Yahoo Finance

Jan 29, 2026

Jan 29, 2026

Will Definium's ‘Rerouting Minds’ LSD Education Push Recast DFTX’s Science-First Psychedelic Narrative? - simplywall.st

Jan 29, 2026

Jan 27, 2026

Certain Pre-funded warrants of Definium Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 28-JAN-2026. - marketscreener.com

Jan 27, 2026

Jan 27, 2026

Breakthrough or Bubble? The High-Stakes 2026 Readouts for Psychedelic Giants - geneonline.com

Jan 27, 2026

Jan 26, 2026

DFTX Stock Price and Chart — NASDAQ:DFTX - TradingView

Jan 26, 2026

Jan 26, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Jan 26, 2026

Jan 25, 2026

Definium Therapeutics (NASDAQ:DFTX) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says - Defense World

Jan 25, 2026

Jan 24, 2026

A Look At Definium Therapeutics (DFTX) Valuation After Rerouting Minds Campaign Highlights Psychedelic LSD Programs - simplywall.st

Jan 24, 2026

Jan 24, 2026

Definium Therapeutics (FRA:MMQ0) Momentum Rank : 2 (As of Jan. 24, 2026) - GuruFocus

Jan 24, 2026

Jan 24, 2026

DFTX: RBC Capital Raises Price Target for Definium Therapeutics - GuruFocus

Jan 24, 2026

Jan 23, 2026

Definium Therapeutics stock price target raised to $36 from $20 at RBC Capital - Investing.com India

Jan 23, 2026

Jan 23, 2026

RBC Raises Price Target on Definium Therapeutics to $36 From $20, Keeps Outperform, Speculative Risk - marketscreener.com

Jan 23, 2026

Jan 22, 2026

Definium Therapeutics (NASDAQ:DFTX) Sets New 52-Week HighHere's What Happened - MarketBeat

Jan 22, 2026

Jan 22, 2026

Deinium Therapeutics (DFTX) Is Up 11.5% After Psychedelic Rebrand And DT120 Roadmap Reveal Has The Bull Case Changed? - Sahm

Jan 22, 2026

Jan 21, 2026

Definium launches educational campaign on LSD for mental health By Investing.com - Investing.com South Africa

Jan 21, 2026

Jan 20, 2026

Definium Therapeutics Launches Educational LSD Campaign to Advance Psychedelic Psychiatry - TipRanks

Jan 20, 2026